Researchers evaluated the efficacy of a new hepatitis C drug combination in helping patients to achieve sustained virologic response, in a new Phase 2 study.
A new study assessed the effects of the addition of a third direct-acting antiviral drug to the combination of sofosbuvir and ledipasvir on the duration of treatment and cure rate in patients with hepatitis...